Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • price cap

    Tag: price cap

    You Searched For "price cap"
    With questions about safety of Merils Made in India BVS stent, NPPA defers its appeal for price exemption

    With questions about safety of Meril's Made in India BVS stent, NPPA defers its appeal for price exemption

    Medical Dialogues Bureau21 Nov 2019 12:09 PM IST
    New Delhi: With an industry association raising health and safety concerns about the flagship Sirolimus-Eluting BioResorbable vascular scaffold system...
    Price cap of Orthopaedic Knee Implants led to boosted sales, says NPPA

    Price cap of Orthopaedic Knee Implants led to boosted sales, says NPPA

    Farhat Nasim11 Sept 2019 6:42 PM IST
    New Delhi: The apex drug price regulator, the National Pharmaceutical Pricing Authority (NPPA) has apprised about the positive impact of capping...
    Indian Stent Maker Translumina sells stake to PE Everstone for Rs 500 crore: Report

    Indian Stent Maker Translumina sells stake to PE Everstone for Rs 500 crore: Report

    Farhat Nasim27 Aug 2019 3:31 PM IST
    Mumbai: Cardiac stents and cardiovascular medical devices maker, Translumina Therapeutics is reported to have sold its minority stake to Private...
    Should Next Gen DES Stents be removed from Price Cap- Govt Panel to Decide

    Should Next Gen DES Stents be removed from Price Cap- Govt Panel to Decide

    Farhat Nasim10 Aug 2019 4:51 PM IST
    NEW DELHI: In a bid to re-enter the market with advanced drug-eluting stents (DES), various medical device makers are in talks with the Government to...
    Price Cap: NLEM Committe to now target intraocular lens, dialysis fluid, hearing aids;

    Price Cap: NLEM Committe to now target intraocular lens, dialysis fluid, hearing aids;

    Farhat Nasim7 Aug 2019 5:30 PM IST
    New Delhi: After fixing the prices of various stents including cardiac stents and orthopaedic implants and even cancer drugs, the government is soon...
    Setback to Sun Pharma: NPPA refuses to give relief of price cap exemption for Gemcitabine

    Setback to Sun Pharma: NPPA refuses to give relief of price cap exemption for Gemcitabine

    Meghna A Singhania17 March 2019 1:33 PM IST
    New Delhi: In a major setback to Sun Pharmaceuticals Ltd, the drug price regulator the National Pharmaceutical Pricing Authority(NPPA) has refused to...
    Setback to Meril Lifesciences MeRess100: NPPA refuses to give relief of price cap exemption for the biodegradable stent

    Setback to Meril Lifesciences MeRess100: NPPA refuses to give relief of price cap exemption for the biodegradable stent

    Meghna A Singhania5 March 2019 5:01 PM IST
    New Delhi: In a major setback to Meril Lifesciences, the drug price regulator National Pharmaceutical Pricing Authority(NPPA) has refused to give it...
    NPPA to decide on Merrills Request for price cap exemption for its biodegradable stent

    NPPA to decide on Merrills Request for price cap exemption for its biodegradable stent

    Meghna A Singhania3 Feb 2019 11:16 AM IST
    New Delhi: A Year after Abbott's launch of biodegradable stents which was later withdrawn globally, Meril Life Sciences has moved the National...
    Relief to Foreign Drugmakers: No price cap on innovative drugs for first five years

    Relief to Foreign Drugmakers: No price cap on innovative drugs for first five years

    Farhat Nasim5 Jan 2019 10:44 AM IST
    New Delhi: Through a recent Gazette notice the Central Government has made amendments to the Drugs Prices Control Orders (DPCO),2013 which aim to...
    HC Rescues Lupin on Price cap on powdered form of asthma drug

    HC Rescues Lupin on Price cap on powdered form of asthma drug

    Ruby Khatun Khatun22 April 2018 11:58 AM IST
    New Delhi: The Delhi High Court directed the Centre not to take any coercive measure against Indian pharma major Lupin Ltd which has challenged a...
    Impose price cap on 19 medical devices notified as drugs : Industry body to NPPA

    Impose price cap on 19 medical devices notified as drugs : Industry body to NPPA

    Ruby Khatun Khatun28 Dec 2017 11:05 AM IST
    The associations asked NPPA to– first and foremost publish data on the trade margins involved in medical devices notified as 'drugs' under the Drugs...
    Cancer, cardiac among 51 essential drugs under NPPA price cap, check out details

    Cancer, cardiac among 51 essential drugs under NPPA price cap, check out details

    Ruby Khatun Khatun24 Nov 2017 4:15 PM IST
    New Delhi: National drug pricing regulator NPPA on Friday said it has capped prices of 51 essential formulations, including those used for the...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok